Bayesian Capital Management’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,327
Closed -$661K 514
2025
Q1
$661K Buy
+28,327
New +$647K 0.11% 247
2024
Q4
Sell
-11,510
Closed -$234K 656
2024
Q3
$234K Buy
+11,510
New +$221K 0.03% 532
2024
Q2
Sell
-13,149
Closed -$383K 687
2024
Q1
$383K Buy
+13,149
New +$301K 0.04% 496
2023
Q4
Sell
-14,300
Closed -$259K 708
2023
Q3
$259K Buy
+14,300
New +$213K 0.03% 502
2023
Q2
Sell
-11,700
Closed -$137K 752
2023
Q1
$137K Buy
+11,700
New +$135K 0.02% 653

Other funds holding ACMR

Bayesian Capital Management's ACMR Position: Q2 2025 in Review

Bayesian Capital Management sold out of ACM Research (ACMR) in Q2 2025, closing a stake of 28,327 shares — an estimated $661K sold.

Bayesian Capital Management first reported a position in ACMR in Q1 2023 and held it in 5 quarters. The position peaked at $661K in Q1 2025. 243 funds tracked by Wall St. Rank hold ACMR as of Q2 2025.

  • Bayesian Capital Management reported no remaining ACM Research position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 28,327 ACM Research shares in Q2 2025, an estimated $661K.
  • Bayesian Capital Management first reported a position in ACM Research in Q1 2023 and held it in 5 quarters.
  • Bayesian Capital Management's ACM Research position peaked at $661K in Q1 2025.
  • 243 funds tracked by Wall St. Rank held ACM Research as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.